Literature DB >> 1451350

A quantitative model for spontaneous bone metastasis: evidence for a mitogenic effect of bone on Walker 256 cancer cells.

P J Kostenuik1, G Singh, K L Suyama, F W Orr.   

Abstract

A new model for the study of spontaneous bone metastasis has been developed which allows for the quantification of metastatic tumor burden and cancer cell growth rate, and which describes the progressive changes in bone morphology. Walker 256 (W256) cells or vehicle were injected into the left upper thigh muscle of male Fischer rats, which were killed 7, 10 or 14 days later. By day 7, metastases had appeared in the distal femur, in the glomeruli of the kidney, and diffusely throughout the liver and lungs. The extent of tumor burden in these organs increased over time. In the femur, 14 days of tumor burden was associated with a 53 +/- 10% decrease in trabecular bone content, a 61 +/- 15% increase in osteoclast surface, and a 95 +/- 10% decrease in osteoblast surface, as compared with non-tumor-bearing controls. By autoradiography, metastatic tumor cells in all organs were determined to have greater growth rates than did cells in the primary tumor. However, within the femur, W256 cells located adjacent to trabecular bone surfaces had a 33 +/- 7% greater growth rate than did W256 cells located > 50 microns from bone surfaces (P < 0.05), suggesting a mitogenic effect of bone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1451350     DOI: 10.1007/bf00133469

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  28 in total

1.  Urinary cyclic AMP and bone histology in Walker carcinosarcoma: evidence of parathyroid hormone-like activity.

Authors:  H Schmidt-Gayk; H Löhrke; A Fischkal; K Goerttler; F Hofmann
Journal:  Eur J Cancer       Date:  1979-10       Impact factor: 9.162

2.  A morphological and phenotypic analysis of Walker 256 cells.

Authors:  H Simpkins; J M Lehman; J E Mazurkiewicz; B H Davis
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

3.  Collagen and collagen-derived fragments are chemotactic for tumor cells.

Authors:  G R Mundy; S DeMartino; D W Rowe
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

4.  Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential.

Authors:  T Turpeenniemi-Hujanen; U P Thorgeirsson; I R Hart; S S Grant; L A Liotta
Journal:  J Natl Cancer Inst       Date:  1985-07       Impact factor: 13.506

5.  Effects of disodium etidronate in murine tumor models.

Authors:  A Guaitani; N Polentarutti; S Filippeschi; L Marmonti; F Corti; C Italia; G Coccioli; M G Donelli; A Mantovani; S Garattini
Journal:  Eur J Cancer Clin Oncol       Date:  1984-05

6.  The hypercalcaemic syndrome in rats bearing the Walker carcinosarcoma 256.

Authors:  H Minne; F Raue; S Bellwinkel; R Ziegler
Journal:  Acta Endocrinol (Copenh)       Date:  1975-03

7.  Growth regulation of cancer metastases by their host organ.

Authors:  N S Sargent; M Oestreicher; H Haidvogl; H M Madnick; M M Burger
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

Review 8.  Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

9.  Binding of formyl peptides to Walker 256 carcinosarcoma cells and the chemotactic response of these cells.

Authors:  D C Rayner; F W Orr; R P Shiu
Journal:  Cancer Res       Date:  1985-05       Impact factor: 12.701

Review 10.  Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatment.

Authors:  J W Elte; O L Bijvoet; F J Cleton; A T van Oosterom; H P Sleeboom
Journal:  Eur J Cancer Clin Oncol       Date:  1986-04
View more
  6 in total

1.  Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion.

Authors:  Guenther G Steger; Rupert Bartsch
Journal:  Ther Adv Med Oncol       Date:  2011-09       Impact factor: 8.168

2.  Transforming growth factor beta upregulates the integrin-mediated adhesion of human prostatic carcinoma cells to type I collagen.

Authors:  P J Kostenuik; G Singh; F W Orr
Journal:  Clin Exp Metastasis       Date:  1997-01       Impact factor: 5.150

Review 3.  Rat models of bone metastases.

Authors:  Stéphane Blouin; Michel Félix Baslé; Daniel Chappard
Journal:  Clin Exp Metastasis       Date:  2006-05-03       Impact factor: 5.150

4.  Breast Cancer: Rank Ligand Inhibition.

Authors:  Rupert Bartsch; Guenther G Steger; Michael Gnant; Reinhard Ziebermayr
Journal:  Breast Care (Basel)       Date:  2010-10-15       Impact factor: 2.860

Review 5.  Mechanisms involved in the metastasis of cancer to bone.

Authors:  F W Orr; P Kostenuik; O H Sanchez-Sweatman; G Singh
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 6.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

Authors:  Ann E Kearns; Sundeep Khosla; Paul J Kostenuik
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.